eLife23h
Molecular consequences of acute versus chronic CDK12 loss in prostate carcinoma nominates distinct therapeutic strategies
(h) LuCaP 189.4 does not express CDK12 protein. Immunohistochemical (IHC) staining (with amplification) for CDK12 on FFPE sections from LuCaP PDX tumors or cell spots from LuCaP189.4_CL and LuCaP189.4 ...